trending Market Intelligence /marketintelligence/en/news-insights/trending/fqcOC3jUXC9TLmwE1cpKPg2 content esgSubNav
In This List

Astorg backs clinical trial tech platform eResearch

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Podcast

Street Talk | Episode 99 - Higher rates punish bond portfolios, weigh on bank M&A

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Astorg backs clinical trial tech platform eResearch

French private equity firm Astorg Partners invested an undisclosed amount in U.S.-based clinical trial technology company, eResearchTechnology Inc., or ERT.

ERT's management team and existing shareholders Nordic Capital and Novo Holdings A/S will reinvest in the company alongside Astorg. Nordic initially invested in the Philadelphia-based data company through its Fund VIII and will reinvest through its Fund IX.

Completion of the transaction is subject to approvals from relevant antitrust authorities.